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Roger F. Haskett 
Introduction 
Many patients with major depressive disorder 
(MDD) develop state-dependent hypotbalamic- 
pituitary-adrenal (HPA) axis dysregulation 
(Carroll et al. 1981). A complex interaction of 
factors contributes to this abnormality. Severity 
of illness (Kumar et al. 1986; Meador-Woodruff 
et al. 1987; Miller and Nelson 1987), age (Ox- 
enkrug et al. 1983; Davis et al. 1984; Lewis et 
al. 1984), and degree of recent weight loss 
(Keitner et al. 1985; Krishnan et al. 1985b) are 
seemingly three of the most important deter- 
minants. 
Severity of depression has been shown to 
correlate moderately with and to contribute sig- 
nificantly to the total variance of postdexame- 
thasone cortisol levels in patients with MDD, 
at both the pituitary and adrenal levels of the 
HPA axis. Many reports, however, have found 
this correlation by studying subjects who were 
operationally defined as either Dexamethasone 
Supp~ss~on Test (DST) nonsupp~ssors or sup- 
pressors. DST nonsuppressors have high post- 
dexamethasone cortisol levels by definition and 
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tend to be more severely depressed than DST 
suppressors (Reus 1982; Sangal et al. 1984; 
Krishnan et al. 1985a). Accordingly, the cor- 
relation between severity of illness and post- 
dexamethasone cortisol levels may be an artifact 
secondary to defining DST suppressor status. 
To examine this possibility, we studied the re- 
lationship between severity of depression and 
postdexamethasone cortisol levels in a group of 
patients with MDD, but with the strategy of 
ev~uating DST suppressors and nonsupp~sso~ 
separately. 
Methods 
Subjects consisted of 114 patients treated in the 
U~ve~i~ of ~c~g~ Depression Program and 
Clinical Studies Unit of the Department of Psy- 
chiatry. All patients underwent a comprehensive 
diagnostic evaluation, including several clinical 
interviews by psychiatrists, a structured inter- 
view by a trained research staff member using 
the Schedule for Affective Disorders and 
Schizophrenia (Spitzer and Endicott 1975), a 
detailed family history and social assessment by 
a social worker, and a thorough physical and 
laboratory evaluation. Diagnosis was made by 
consensual agreement of the clinicians involved 
in gathering the above information using Re- 
search Diagnostic Criteria (RDC) (Spitzer et al. 
1977). 
Patients included in the present study (1) met 
RDC for MDD, (2) did not meet psychotic sub- 
type, (3) completed a DST fo~ow~g a medi- 
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cation-free period of at least 2 weeks, (4) had 
a U-item Hamilton Rating Scale for Depression 
(HSRD) (Hamilton 1960) administered at the 
time of the DST, (5) had no identifiable tech- 
nical exclusions known to invalidate the DST 
(Carroll et al. 1981), and (6) gave written in- 
formed consent to participate in these research 
activities. 
Samples were obtained for postdexametha- 
sane plasma cortisol determination at 8:00 AM, 
4:oO PM, and 1 1:OO PM, ~though fewer than alt 
three samples were obtained from most patients 
(8:OO AM, n = 20; 4:OO PM, n = 112, 11:00 
PM, n = 5 I ). We dete~ined plasma cortisol 
concentration using a modification of Murphy’s 
( 1967) competitive protein-binding technique. 
Maximum ~stdexamethasone plasma cortisof 
levels were logarithmically transformed to im- 
prove normality prior to correlational analyses. 
We defined DST nonsuppression as a maximum 
postdexamethasone plasma cortisol level 3 5 
pg/dl . Comparisons between DST suppressors 
and nonsuppressors were by two-tailed t-tests 
or the X2 test, as appropriate. 
Results 
A highly signific~t correlation was found be- 
tween HRSD scores and maximum postdexa- 
methasone plasma cortisol levels for the entire 
patient population, as shown in Figure I, gen- 
erating the regression equation y = - 2.48 + 
0.36x (n = 114, df = 112, r = 0.40, p --c 
0.0001). When divided into DST suppressors 
and nonsuppressors, the same general relation- 
ship persisted: the nonsuppressors manifested a 
significant relationship between HRSD scores 
and maximum postdexamethasone plasma cor- 
tisol levels (y = 1.93 + 0.41 x; n = 34, df 
= 32, Y = 0.44, p < O-01), as did the DST 
suppressors (y = 0.99 + 0.041x; n = 80, df 
ZZ 78, r = 0.22, p < 0.05). 
Given earlier reports suggesting that age and 
degree of recent weight loss are also important 
determinants of the HPA axis dysregulation seen 
in depression, the influence of these variables 
on the observed severity-cortisol relationship 
was determined. HRSD scores, age, and degree 
of recent weight loss were entered into a mul- 
tiple linear regression analysis with postdexa- 
methasone plasma cortisol as the dependent 
variable. For the entire study group, a significant 
relationship was found (multiple Y = 0.48, p 
< 0.0001). Partial correlation coefficients were: 
HRSD score, r = 0.29 (p < 0.002); age, r = 
0.30 (p < 0.002); and weight loss, r = 0.07. 
When only the nonsuppressors were studied, a 
similar correlation was found (multiple r = 0.47, 
p = 0.06). In h t is case, partial correlation coef- 
ficients were: HRSD score, r = 0.42 {p < 0.02); 
age, r = 0.13; and weight loss, r = 0.17. 
Finaby, when the DST suppressors were stud- 
ied, a significant relationship was found (mul- 
tiple r = 0.35, p < 0.02), with partial corre- 
lation coefficients of 0. f8 (p = 0.12), 0.24 (p 
< 0.05), and 0.11 for HRSD score, age, and 
weight loss, respectively. Age and severity, but 
not weight loss, appear to be factors contributing 
to the HPA axis dysregulation observed in this 
particular group of patients. When the effects 
of age and weight loss are accounted for, sig- 
nificant relationships between HRSD score and 
postdexamethasone plasma cortisol persist for 
the entire group and for the DST nonsuppres- 
sors; the relationship between these two vari- 
ables exhibits a trend toward significance for the 
DST suppressors I 
To explore possible differences between the 
DST suppressors and nonsuppressors, various 
clinical and demographic variables were com- 
pared, as indicated in Table I. The DST non- 
suppressors were signific~tly older and more 
severely depressed than the suppressors, whereas 
other factors were not appreciably different. 
Discussion 
A growing number of studies concur that se- 
verity of depression is a significant determinant 
of the HPA axis dysregulation associated with 
MDD (Kumar et al. 1986; Meador-W~ff et 
al. 1987; Miller and Nelson 1987). Our results 
indicate that this relationship is not simply an 
artifact related to the definition of DST sup- 
pressors and nonsuppressors. Rather, both DST 
suppressors and nonsuppressors exhibit a sig- 
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Figure 1. Scattergram of HRSD scores and m~imum ~s~ex~e~asone plasma cortisoi IeveIs, Dashed 
tine indicates division between DST suppressors and nonsuppressors. Center regression line is for the entire 
population; upper and lower lines represent DST nonsuppressors and suppressors, respectively. All three 
regression lines are statistically significant. 
Table 1. Clinical and Demographic Variables of DST Suppressors and Nonsuppressors 




Weight change (kg) 








37.3 rf: 14.2” 47.0 +- 16.2 
17.9 i 5.3 21.6 t 5.4 
+0.6Or8.9 - 2.59 a 8.1 




1.73 -I: 0.12 10.9 -f 4.32 
21f13 x2 = 0.00 NS 
26f8 x2 = 0.07 NS 
t = 3.18 <0.002 
r = 3.32 <o.OiE 
t = -1.74 NS 
t = 0.01 NS 
x2 = 1.51 NS 
t = 15.6 <o.o001 
plasma cortisol (ug/dl) 




nificant ~~ationship between m~imum post- 
dexamethasone plasma cortisol levels and HRSD 
scores, just as the total combined population 
does. Although differences in degree of severity 
of depression exist between the DST suppres- 
sors and nonsuppressors, both manifest a cor- 
relational relationship between severity of 
depression and plasma cortisol, even when the 
effects of age and degree of recent weight loss 
are accounted for. 
not be overemphasized or used in isolation, es- 
pecially in studies attempting to explore the 
physiology of this system. A relationship exists 
between maximum ~stdexame~asone plasma 
cortisol levels and severity of depression, re- 
These results also suggest that the use of a 
cutpoint of postdex~e~asone plasma cortisol 
ievels should be used in conjunction with other 
measures when studying the neuroendocrinol- 
ogy of depression. Originally, the DST was 
standardized in an attempt to find a laboratory 
correlate specific to endogenous depression 
(Carroll et al. 1981). Although referent values 
may be essential for determining sensitivity and 
specificity, our results indicate that they should 
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